[HTML] thieme-connect.com

[HTML][HTML] Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign

GR Cameron, PV Desmond… - Endoscopy …, 2016 - thieme-connect.com
Background and study aims: Radiofrequency ablation (RFA) combined with endoscopic
mucosal resection (EMR) is effective for eradicating dysplastic Barrett's esophagus. The …
被引用次数：9 相关文章
[HTML] nih.gov

[HTML][HTML] Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign

GR Cameron, PV Desmond… - Endoscopy …, 2016 - ncbi.nlm.nih.gov
Background and study aims: Radiofrequency ablation (RFA) combined with endoscopic
mucosal resection (EMR) is effective for eradicating dysplastic Barrett's esophagus. The …

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign

GR Cameron, PV Desmond… - Endoscopy …, 2016 - pubmed.ncbi.nlm.nih.gov
Background and study aims Radiofrequency ablation (RFA) combined with endoscopic
mucosal resection (EMR) is effective for eradicating dysplastic Barrett's esophagus. The …

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign.

GR Cameron, PV Desmond… - Endoscopy …, 2016 - europepmc.org
Results In total, 137 patients received RFA (78 with EMR); 75 with over 12 months follow-up
since commencing RFA. Pretreatment histology was intramucosal cancer (IMC) 21%, high …

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign.

GR Cameron, PV Desmond… - Endoscopy …, 2016 - europepmc.org
Results In total, 137 patients received RFA (78 with EMR); 75 with over 12 months follow-up
since commencing RFA. Pretreatment histology was intramucosal cancer (IMC) 21%, high …